Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
17%
Ph not_applicable
4
67%
Ph phase_2
1
17%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(5)

Detailed Status

Completed5
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (16.7%)
Phase 31 (16.7%)
N/A4 (66.7%)

Trials by Status

enrolling_by_invitation117%
completed583%

Recent Activity

0 active trials
Showing 5 of 6
enrolling_by_invitationnot_applicable

Effect of Omega-3 Supplementation on Pregnant Outcomes and Inflammation Markers of Women Infected With HIV Using Antiretroviral Therapy

NCT06971445
completednot_applicable

26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Memory Consolidation in Healthy Adults

NCT03592251
completednot_applicable

26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Sleep Efficiency in Healthy Adults

NCT03559361
completednot_applicable

26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Cerebral Blood Flow in Healthy Adults

NCT03158545
completedphase_2

Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia

NCT00585390
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06971445Not Applicable

Effect of Omega-3 Supplementation on Pregnant Outcomes and Inflammation Markers of Women Infected With HIV Using Antiretroviral Therapy

Enrolling By Invitation
NCT03592251Not Applicable

26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Memory Consolidation in Healthy Adults

Completed
NCT03559361Not Applicable

26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Sleep Efficiency in Healthy Adults

Completed
NCT03158545Not Applicable

26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Cerebral Blood Flow in Healthy Adults

Completed
NCT00585390Phase 2

Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia

Completed
NCT00251134Phase 3

OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction

Completed

All 6 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
6